Published on: 2 December 2020 Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers more
Published on: 2 December 2020 Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies more
Subscribe to Roche News Xổ số miền nam thứ 7 tuần trướcGet the latest news and updates to your inbox. more
Media library Xổ số miền nam thứ 7 tuần trướcBrowse and download multimedia resources including images and videos more